111 related articles for article (PubMed ID: 35797753)
1. Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients.
da Costa WL; Gu X; Farjah F; Groth SS; Burt BM; Ripley RT; Massarweh NN
J Surg Res; 2022 Nov; 279():256-264. PubMed ID: 35797753
[TBL] [Abstract][Full Text] [Related]
2. Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.
da Costa WL; Tran Cao HS; Gu X; Massarweh NN
Ann Surg; 2022 Mar; 275(3):415-421. PubMed ID: 35120060
[TBL] [Abstract][Full Text] [Related]
3. Impact of Staging Concordance and Downstaging After Neoadjuvant Therapy on Survival Following Resection of Intrahepatic Cholangiocarcinoma: A Bayesian Analysis.
Alaimo L; Moazzam Z; Lima HA; Endo Y; Woldesenbet S; Ejaz A; Cloyd J; Guglielmi A; Ruzzenente A; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4799-4808. PubMed ID: 37029867
[TBL] [Abstract][Full Text] [Related]
4. Understanding the association between clinical staging accuracy, treatment response, and survival among gastric cancer patients through Bayesian analysis.
da Costa WL; Tran Cao HS; Gu X; Massarweh NN
J Surg Oncol; 2022 Nov; 126(6):986-994. PubMed ID: 35819061
[TBL] [Abstract][Full Text] [Related]
5. Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma.
da Costa WL; Gu X; Farjah F; Groth SS; Burt BM; Ripley RT; Carrott PW; Massarweh NN
Ann Thorac Surg; 2022 Jan; 113(1):279-285. PubMed ID: 33484675
[TBL] [Abstract][Full Text] [Related]
6. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis.
da Costa WL; Tran Cao HS; Sheetz KH; Gu X; Norton EC; Massarweh NN
Ann Surg Oncol; 2021 Jun; 28(6):3186-3195. PubMed ID: 33174146
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of Clinical Staging and Outcome With Primary Resection for Local-Regionally Limited Esophageal Adenocarcinoma.
Worrell SG; Alicuben ET; Oh DS; Hagen JA; DeMeester SR
Ann Surg; 2018 Mar; 267(3):484-488. PubMed ID: 28151801
[TBL] [Abstract][Full Text] [Related]
9. The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
Janczewski LM; Shah D; Wells A; Bentrem DJ; Abad JD; Chawla A
J Surg Oncol; 2023 Jun; 127(7):1116-1124. PubMed ID: 36905333
[TBL] [Abstract][Full Text] [Related]
10. Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.
Dijksterhuis WPM; Hulshoff JB; van Dullemen HM; Kats-Ugurlu G; Burgerhof JGM; Korteweg T; Mul VEM; Hospers GAP; Plukker JTM
Acta Oncol; 2019 Nov; 58(11):1640-1647. PubMed ID: 31397195
[No Abstract] [Full Text] [Related]
11. Magnetic resonance imaging accuracy in staging early and locally advanced rectal cancer.
Arndt K; Vigna C; Kaul S; Fabrizio A; Cataldo T; Smith M; Messaris E
Surg Oncol; 2023 Oct; 50():101987. PubMed ID: 37717374
[TBL] [Abstract][Full Text] [Related]
12. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
13. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma.
Levenson G; Voron T; Paye F; Balladur P; Debove C; Chafai N; De Dios AG; Lefevre JH; Parc Y
Surgery; 2021 Dec; 170(6):1711-1717. PubMed ID: 34561115
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.
Mokdad AA; Minter RM; Zhu H; Augustine MM; Porembka MR; Wang SC; Yopp AC; Mansour JC; Choti MA; Polanco PM
J Clin Oncol; 2017 Feb; 35(5):515-522. PubMed ID: 27621388
[TBL] [Abstract][Full Text] [Related]
15. Inaccurate Clinical Stage Is Common for Gastric Adenocarcinoma and Is Associated with Undertreatment and Worse Outcomes.
Ju MR; Karalis JD; Blackwell JM; Mansour JC; Polanco PM; Augustine M; Yopp AC; Zeh HJ; Wang SC; Porembka MR
Ann Surg Oncol; 2021 May; 28(5):2831-2843. PubMed ID: 33389294
[TBL] [Abstract][Full Text] [Related]
16. Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment?
Perez Holguin RA; Olecki EJ; Stahl KA; Wong WG; Vining CC; Dixon MEB; Peng JS
J Gastrointest Surg; 2022 Oct; 26(10):2050-2060. PubMed ID: 36042124
[TBL] [Abstract][Full Text] [Related]
17. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
Speicher PJ; Ganapathi AM; Englum BR; Hartwig MG; Onaitis MW; D'Amico TA; Berry MF
J Thorac Oncol; 2014 Aug; 9(8):1195-201. PubMed ID: 25157773
[TBL] [Abstract][Full Text] [Related]
18. ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer.
Zanoni A; Verlato G; Giacopuzzi S; Motton M; Casella F; Weindelmayer J; Ambrosi E; Di Leo A; Vassiliadis A; Ricci F; Rice TW; de Manzoni G
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):998-1004. PubMed ID: 27480358
[TBL] [Abstract][Full Text] [Related]
19. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
[TBL] [Abstract][Full Text] [Related]
20. Inaccurate pretreatment staging can impact survival in early stage esophageal adenocarcinoma.
Scholer AJ; Uppal A; Chang SC; Ghosh D; Garland-Kledzik M; Santamaria-Barria J; Khader A; Dehal A; Fischer T; Goldfarb M
J Surg Oncol; 2020 Oct; 122(5):914-922. PubMed ID: 32632944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
